Jump to Main Content

Highlights of ASH in Asia-Pacific

Highlights of ASH in Asia-Pacific


About Highlights of ASH in Asia-Pacific

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care. 

Through participation in this meeting, you will be able to:

Blood icon

Explore a program that covers the latest and most influential topics in hematology curated from the premier science presented at the ASH annual meeting.

icon for engage interaction-an avatar looking at the screen

Actively engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.

An icon for a group of experts

Network with speakers, exhibitors, and peers in a close-knit setting.

Community Connection Icon

Connect with a community of individuals who share common goals and hold a mutual appreciation for the scientific advancements.

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Program Co-Host

ASH is proud to co-host this meeting with the Malaysian Society of Hematology.

Program Co-Chairs

The Program Co-Chairs for the Highlights of ASH in Asia-Pacific are: 

  • Malaysian Society of Hematology Program Co-Chairs 
    • Dr. Gin Gin Gan 
    • Dr. Haris Abdul Rahman 
  • American Society of Hematology Program Co-Chairs 
    • Dr. Payal Desai
    • Dr. Eric Tse 

Program Schedule

The following session topics correspond to the 2026 Highlights of ASH in Asia-Pacific and is subject to change.

8:00 – 8:45 a.m. Registration and Exhibits Open 
8:45 - 9:00 a.m. Welcome & Introductions
9:00 - 9:30 a.m. Acute Myeloid Leukemia

Katherine Tarlock, MD
University of Washington
Seattle, WA
9:30 - 10:00 a.m.   Acute Lymphoblastic Leukemia

Adele K Fielding, MBBS, PhD
Hull York Medical School
Hull, England
10:00 - 10:30 a.m.  

Panel Discussion

10:30 - 11:00 a.m. Coffee Break in the Exhibit Hall
11:00 - 11:45 a.m. Hemoglobinopathies & Red Blood Cell Disorders Payal Desai, MD
Wake Forest University
Winston-Salem, NC
11:45 a.m. - 12:15 p.m. Artificial Intelligence & Informatics in Hematology Practice Improvement

Barbara Lam, MD
Fred Hutchinson Cancer Center
Seattle, WA
12:15 - 12:45 p.m. Panel Discussion
12:45 - 2:00 p.m. Lunch in the Exhibit Hall (All Attendees) 
Lunch with the Experts (Ticketed)  
2:00 - 3:15 p.m. Tumor Board: Plasma Cell Disorders 

Gin Gin Gan, MD
Universiti Malaya
Kuala Lumpur, Malaysia

Shaji Kumar, MD
Mayo Clinic
Rochester, MN

Hang Quach, MBBS, MD
St. Vincent's Hospital
Melbourne, Australia
3:15 - 3:45 p.m. Coffee Break in the Exhibit Hall 
3:45 - 4:15 p.m.   Histiocytic Disorders 

Gaurav Goyal, MD
University of Alabama
Birmingham, AL
4:15 - 4:45 p.m. Immune Cytopenias 

Michael A. Cole, MD, Dphil
Johns Hopkins Medicine
Baltimore, MD
4:45 - 5:15 p.m. Panel Discussion
5:15 - 5:20 p.m. Highlights of ASH Day 1 Closing Remarks   

Sarah O'Brien, MD
Nationwide Children's
Columbus, OH
8:00 – 8:45 a.m. Registration and Exhibits Open 
8:45 - 9:00 a.m. Welcome & Introductions
9:00 - 9:30 a.m. Bleeding Disorders 

Ross Baker, MBBS
Perth Blood Institute
Perth, Australia
9:30 - 10:00 a.m. Women's Health 

10:00 - 10:30 a.m. Panel Discussion  
10:30 - 11:00 a.m. Coffee Break in the Exhibit Hall 
11:00 a.m. - 12:15 p.m. Case-Based Presentation: Thrombosis 

Panelist 1:
Ponlapat Rojnuckarin, MD, PhD
Bumrungrad International Hospital
Bangkok, Thailand

Panelist 2:
Jeffrey Weitz, MD
McMaster University
Ontario, Canada

Panelist 3:
Lee Lai Heng, MBBS, MD
Singapore General Hospital
Singapore
12:15 - 1:30 p.m. Lunch in the Exhibit Hall (All Attendees) 
Lunch with the Experts (Ticketed)  
1:30 - 2:00 p.m. Indolent Lymphoma and Chronic Lymphocytic Leukemia 

Jia Ruan, MD, PhD
Weill Cornell Medicine
New York, NY
2:00 - 2:45 p.m. Aggressive Lymphoma 

Steven Park, MD
Wake Forest University
Winston-Salem, NC

Eric Tse, MBBS, PhD
Hong Kong University
2:45 - 3:15 p.m. Panel Discussion
3:15 - 3:45 p.m. Coffee Break in the Exhibit Hall 
3:45 - 4:30 p.m. Transplant 

Robert Negrin, MD
Stanford University
Stanford, California

William Hwang, MBBS
National Cancer Center Singapore
4:30 - 5:00 p.m. Myelodysplastic Syndromes & Myeloproliferative Neoplasms  

Harry Gill Singh, MBBS
HKU Med
Hong Kong
5:00 - 5:30 p.m. Panel Discussion
5:30 p.m.   Highlights of ASH in Asia-Pacific Closing Remarks